Dauch Corporation (DCH) Key Metrics
DCH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.15B
- Enterprise value
- $5.67B
- P/E (TTM)
- — 10-yr median 14.0
- Forward P/E
- 5.9
- PEG ratio
- 0.43
- Price / sales
- 0.1 10-yr median 0.2
- Price / book
- 0.9 10-yr median 1.4
- EV / EBITDA
- 7.7 10-yr median 5.5
- Dividend yield
- —
- Beta
- 1.69
DCH key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsDCH valuation Price multiples at each fiscal year-end price.
DCH returns How much profit the business earns on the capital it uses.
DCH per-share figures Results divided by the shares outstanding at year-end.
DCH financial health Debt, liquidity and how easily interest is covered.
DCH efficiency & capital use Working capital cycle and where the cash goes.
DCH valuation history
DCH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DCH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DCH cash returned to shareholders
DCH price vs earnings per share
DCH key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $758.9M | $710.7M | $1.03B | $903.2M | $1.10B | $943.3M | $1.21B | $1.24B | $1.75B | $1.48B |
| Enterprise value | $4.22B | $2.90B | $3.39B | $3.53B | $3.80B | $3.96B | $4.44B | $4.57B | $5.35B | $2.41B |
| P/E ratio | — | 20.3 | — | 14.0 | 186.6 | — | — | — | 5.2 | 6.2 |
| Price / sales | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 |
| Price / book | 1.2 | 1.3 | 1.7 | 1.4 | 2.4 | 2.5 | 1.2 | 0.8 | 1.1 | 2.8 |
| Price / free cash flow | 5.1 | 3.5 | 5.2 | 3.3 | 3.1 | 3.9 | 9.6 | 5.0 | 10.3 | 8.0 |
| Price / operating cash flow | 1.8 | 1.6 | 2.6 | 2.0 | 2.0 | 2.1 | 2.2 | 1.6 | 2.7 | 3.6 |
| EV / sales | 0.7 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.7 | 0.6 | 0.9 | 0.6 |
| EV / EBITDA | 6.4 | 4.0 | 5.1 | 4.8 | 5.1 | 31.9 | 20.1 | 7.7 | 5.9 | 4.0 |
| EV / free cash flow | 28.3 | 14.2 | 17.0 | 12.9 | 10.6 | 16.6 | 35.1 | 18.5 | 31.6 | 13.0 |
| Earnings yield | −2.6% | 4.9% | −3.3% | 7.1% | 0.5% | −59.5% | −40.0% | −4.6% | 19.3% | 16.2% |
| Free cash flow yield | 19.7% | 28.7% | 19.4% | 30.3% | 32.4% | 25.3% | 10.4% | 19.9% | 9.7% | 12.4% |
| Shareholder yield (dividends + buybacks) | 0.4% | 0.4% | 1.4% | 0.2% | 0.4% | 0.3% | 0.6% | 0.3% | 0.4% | 0.4% |
| Share price at fiscal year-end | $6.41 | $5.83 | $8.81 | $7.82 | $9.33 | $8.34 | $10.76 | $11.10 | $17.03 | $19.30 |
| Per share | ||||||||||
| Revenue per share | $49.30 | $50.25 | $52.14 | $50.24 | $43.70 | $41.65 | $58.00 | $65.15 | $60.95 | $51.34 |
| Earnings per share | −$0.17 | $0.29 | −$0.29 | $0.56 | $0.05 | −$4.96 | −$4.30 | −$0.52 | $3.28 | $3.13 |
| Operating cash flow per share | $3.48 | $3.74 | $3.40 | $3.89 | $4.56 | $4.02 | $4.97 | $6.91 | $6.29 | $5.30 |
| Free cash flow per share | $1.26 | $1.68 | $1.71 | $2.37 | $3.03 | $2.11 | $1.12 | $2.21 | $1.65 | $2.40 |
| Cash per share | $5.99 | $4.54 | $4.46 | $4.43 | $4.49 | $4.92 | $4.72 | $4.27 | $3.67 | $6.26 |
| Book value per share | $5.41 | $4.62 | $5.19 | $5.43 | $3.88 | $3.28 | $8.68 | $13.30 | $14.98 | $6.89 |
| Tangible book value per share | $0.76 | −$0.54 | −$0.94 | −$1.48 | −$3.59 | −$5.27 | −$5.20 | −$6.89 | −$12.91 | $4.52 |
| Capex per share | $2.22 | $2.06 | $1.69 | $1.52 | $1.54 | $1.91 | $3.85 | $4.70 | $4.65 | $2.90 |
| Debt per share | $35.26 | $22.46 | $24.75 | $27.14 | $27.36 | $31.58 | $33.39 | $34.13 | $38.67 | $18.26 |
| Shares outstanding | 118.4M | 121.9M | 116.6M | 115.5M | 118.0M | 113.1M | 112.6M | 111.6M | 102.8M | 76.9M |
| Change in shares outstanding | −2.9% | +4.5% | +1.0% | −2.1% | +4.3% | +0.4% | +0.9% | +8.6% | +33.7% | +0.8% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −3.3% | 6.0% | −5.5% | 11.9% | 1.4% | −83.3% | −39.4% | −3.8% | 32.6% | 57.9% |
| Return on invested capital (ROIC) | 3.4% | 4.7% | 3.7% | 7.4% | 7.4% | −8.2% | −5.3% | 1.7% | 16.4% | 21.5% |
| Return on assets (ROA) | −0.3% | 0.7% | −0.6% | 1.2% | 0.1% | −8.9% | −6.8% | −0.7% | 6.0% | 7.2% |
| Return on tangible assets | −0.3% | 0.8% | −0.7% | 1.4% | 0.1% | −11.3% | −9.5% | −1.1% | 6.7% | 7.4% |
| Free cash flow margin | 2.6% | 3.3% | 3.3% | 4.7% | 6.9% | 5.1% | 1.9% | 3.4% | 2.7% | 4.7% |
| Income quality (OCF / net income) | — | 13.01 | — | 6.98 | 91.25 | — | — | — | 1.92 | 1.69 |
| Financial health | ||||||||||
| Total debt | $4.17B | $2.74B | $2.89B | $3.13B | $3.23B | $3.57B | $3.76B | $3.81B | $3.98B | $1.40B |
| Cash & short-term investments | $708.9M | $552.9M | $519.9M | $511.5M | $530.2M | $557.0M | $532.0M | $476.4M | $376.8M | $481.2M |
| Net debt | $3.47B | $2.18B | $2.37B | $2.62B | $2.70B | $3.02B | $3.23B | $3.33B | $3.60B | $923.0M |
| Debt / equity | 6.52 | 4.86 | 4.77 | 5.00 | 7.05 | 9.64 | 3.85 | 2.57 | 2.58 | 2.65 |
| Debt / assets | 0.63 | 0.54 | 0.54 | 0.57 | 0.57 | 0.60 | 0.57 | 0.51 | 0.50 | 0.41 |
| Net debt / EBITDA | 5.22 | 3.04 | 3.56 | 3.58 | 3.64 | 24.33 | 14.59 | 5.63 | 3.94 | 1.53 |
| Current ratio | 2.95 | 1.63 | 1.67 | 1.66 | 1.78 | 1.92 | 1.81 | 1.50 | 1.60 | 2.05 |
| Quick ratio | 2.57 | 1.25 | 1.27 | 1.28 | 1.39 | 1.59 | 1.45 | 1.16 | 1.28 | 1.71 |
| Interest coverage | 1.2 | 1.3 | 0.7 | 1.4 | 1.2 | -1.9 | -1.4 | 0.5 | 2.8 | 4.1 |
| Working capital | $2.40B | $739.6M | $805.0M | $794.1M | $816.1M | $897.7M | $831.4M | $673.0M | $728.6M | $685.0M |
| Invested capital | $4.11B | $2.75B | $2.97B | $3.25B | $3.16B | $3.39B | $4.21B | $4.82B | $5.14B | $1.45B |
| Tangible asset value | $90.4M | −$65.9M | −$110.0M | −$170.5M | −$423.3M | −$593.2M | −$583.2M | −$766.6M | −$1.33B | $347.5M |
| Net current asset value | −$2.40B | −$2.58B | −$2.74B | −$2.85B | −$3.32B | −$3.67B | −$3.81B | −$3.99B | −$4.40B | −$1.58B |
| Graham number | — | $5.46 | — | $8.25 | $2.09 | — | — | — | $33.25 | $22.03 |
| Graham net-net per share | −$38.33 | −$26.18 | −$28.96 | −$30.16 | −$32.80 | −$37.40 | −$38.49 | −$41.16 | −$48.57 | −$24.80 |
| Capital allocation | ||||||||||
| Share buybacks (net) | $2.8M | $2.8M | $14.7M | $1.9M | $4.3M | $2.7M | $7.5M | $3.7M | $7.0M | $5.2M |
| Dividends + buybacks / free cash flow | 1.9% | 1.4% | 7.4% | 0.7% | 1.2% | 1.1% | 5.9% | 1.5% | 4.1% | 2.8% |
| Capex / revenue | 4.5% | 4.1% | 3.2% | 3.0% | 3.5% | 4.6% | 6.6% | 7.2% | 7.6% | 5.6% |
| Capex / operating cash flow | 63.7% | 55.1% | 49.7% | 39.1% | 33.7% | 47.4% | 77.4% | 68.0% | 73.8% | 54.7% |
| Capex / depreciation | 0.57 | 0.53 | 0.40 | 0.36 | 0.33 | 0.41 | 0.81 | 0.99 | 1.11 | 1.11 |
| Stock-based compensation / revenue | 0.2% | 0.2% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | 0.4% | 0.7% | 0.5% |
| R&D / revenue | 2.5% | — | 2.6% | 2.5% | 2.3% | — | — | 2.0% | 2.6% | 3.5% |
| SG&A / revenue | 6.7% | 6.3% | 6.0% | 5.9% | 6.7% | — | — | 5.3% | 6.2% | 8.1% |
| Efficiency | ||||||||||
| Days sales outstanding | 45.1 | 45.5 | 49.2 | 49.8 | 55.1 | 62.3 | 49.8 | 50.3 | 46.5 | 50.8 |
| Days of inventory on hand | 31.8 | 31.4 | 31.7 | 31.3 | 30.2 | 30.8 | 27.0 | 25.4 | 21.7 | 25.5 |
| Days payables outstanding | 49.7 | 50.0 | 50.4 | 48.2 | 49.1 | 53.2 | 47.5 | 48.8 | 41.9 | 45.0 |
| Cash conversion cycle (days) | 27.2 | 26.9 | 30.4 | 32.9 | 36.2 | 40.0 | 29.4 | 26.8 | 26.3 | 31.3 |
| Receivables turnover | 8.09 | 8.02 | 7.42 | 7.33 | 6.63 | 5.86 | 7.33 | 7.26 | 7.85 | 7.18 |
| Payables turnover | 7.35 | 7.30 | 7.24 | 7.57 | 7.44 | 6.87 | 7.69 | 7.48 | 8.71 | 8.11 |
| Inventory turnover | 11.47 | 11.63 | 11.52 | 11.66 | 12.09 | 11.85 | 13.51 | 14.39 | 16.83 | 14.32 |
| Asset turnover | 1.00 | 1.18 | 1.12 | 1.04 | 0.89 | 0.75 | 0.92 | 0.94 | 1.11 | 1.19 |
| Average receivables | $721.0M | $763.8M | $819.4M | $791.5M | $778.0M | $804.3M | $891.0M | $1.00B | $798.0M | $549.5M |
| Average payables | $709.4M | $737.2M | $754.0M | $673.4M | $595.9M | $601.2M | $731.9M | $819.6M | $590.6M | $397.5M |
| Average inventory | $454.4M | $462.7M | $473.4M | $437.1M | $366.8M | $348.4M | $416.6M | $425.9M | $305.8M | $225.0M |
| Intangibles / total assets | 8.2% | 12.4% | 13.3% | 14.6% | 15.6% | 16.3% | 23.5% | 30.0% | 36.4% | 5.3% |
Computed from DCH's annual financial statements (latest annual report filed February 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DCH valuation and financial ratios
Dauch earned a return on equity of −3.3% and a return on invested capital of 3.4% in fiscal 2025. It ended the year with $4.2 billion of debt and $708.9 million in cash and short-term investments, net debt of $3.5 billion. It returned $2.8 million to shareholders: $0 in dividends and $2.8 million in share buybacks, 2% of free cash flow. The share count rose 54.0% from 76.9M to 118.4M over 9 years.
See the DCH income statement, the DCH chart for price history, or the DCH stock overview for the latest quote and news.
DCH key metrics FAQ
What is Dauch's EV/EBITDA?
Dauch's enterprise value was 6.4 times EBITDA at the end of fiscal 2025 (enterprise value $4.2 billion, EBITDA $663.5 million); the current EV/EBITDA is 7.7.
What is Dauch's return on equity?
Dauch's return on equity (ROE) was −3.3% in fiscal 2025: net income of -$19.7 million on average shareholders' equity of $601.4 million.
What is Dauch's ROIC?
Dauch's return on invested capital was 3.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Dauch have?
Dauch had total debt of $4.2 billion at the end of fiscal 2025, a debt-to-equity ratio of 6.52 and $3.5 billion of net debt (5.22 times EBITDA).
Does Dauch buy back its shares?
Yes. Dauch spent $2.8 million on net share repurchases in fiscal 2025 Shares outstanding changed −2.9% over the year, to 118.4M..
What is Dauch's free cash flow yield?
Dauch generated $149.3 million of free cash flow in fiscal 2025, a free cash flow yield of 19.7% on its market value at year-end ($758.9 million).
What is Dauch's current ratio?
Dauch's current ratio was 2.95 at the end of fiscal 2025: current assets were 2.95 times current liabilities.